Topic Archives: Draper Laboratories

Comments

  • Avatar

    $AKBA Long Akebia recent selloff not based on fundamentals, says H.C. Wainwright H.C. Wainwright analyst Ed Arce no...

  • DrKSSMDPhD

    Great coverage from you this am admdr5. $AKBA remains as close to a sure thing as one gets in biotech. It and Fibrogen w...

  • SoGiAm

    $TEVA np - seeking partners to fund some drug development- Reuters https://twitter.com/odibro/status/8977676779173765...

  • Avatar

    $AKAB. Long Akebia Therapeutics announces the EPO has revoked FibroGen's (FGEN) HIF-related patent in Europe and anno...

  • DrKSSMDPhD

    Hi lev: This is another situation where two companies are in a race and vying for the same space: here it's Cambridge-ba...

  • DrKSSMDPhD

    Puts $AKBA ahead by a nose vs FibroGen. Long $AKBA. Company pretty gapingly undervalued here....

  • DrKSSMDPhD

    In the Akebia vs FibroGen faceoff, I've always backed Akebia, as per our 2014 column. Better agent, better science. (I s...

  • DrKSSMDPhD

    Hi Zimmy: I'm pretty strongly confident in the abilities of the drugs of both Fibrogen and Akebia to really wring out th...

  • SoGiAm

    Dr. KSS MD PhD, author of this article, says: October 2, 2015 at 10:43 am http://www.stockgumshoe.com/2015/09/the-tao-of...

  • SoGiAm

    glenn newberry says: August 28, 2015 at 5:08 pm http://www.stockgumshoe.com/2015/08/cellceutix-23-minutes-with-leo-ehrli...

  • SoGiAm

    ans_chandra says: May 20, 2015 at 8:26 pmhttp://www.stockgumshoe.com/2015/05/cisco-chang-charlie/comment-page-3/#commen...

  • SoGiAm

    Fibrogen - February 16, 2015 at 3:41 pm http://www.stockgumshoe.com/2015/02/saving-jack-kerouac/comment-page-4/#comment-...

  • SoGiAm

    Fibrogen: http://www.stockgumshoe.com/2014/06/microblog-is-this-red-hot-new-blood-stock-any-bloody-good-as-an-investmen...

  • SoGiAm

    Dr. KSS, MD PhD says: January 5, 2015 at 5:49 pm http://www.stockgumshoe.com/2014/12/the-finale-is-grand-the-gain-from-...

  • SoGiAm

    $FGEN- FibroGen Announces Publication of Phase 2 Study Results Supporting the Potential of FG-3019 to Treat Patients Wit...

  • SoGiAm

    AGEN, AKBA, PIRS, FLKS: Extracted from: http://www.thelifesciencesreport.com/pub/na/panelists-select-19-companies-for-t...

  • DrKSSMDPhD

    Hi Dan: no real catalyst so much as chatter about how undervalued it is, that investors are starting to notice it's been...

  • Avatar

    It appears that Akebia (AKBA) came out on top of this patent ruling with main competitor Fibrogen (FGEN) today. Long AKB...

  • DrKSSMDPhD

    UBS reiterates buy rating today on $AKBA, with 12 mo PT in line with mine of $16....this is premised on a 40 percent cha...

  • DBMD

    Long case for Receptos Dr. KSS, MD PhD, author of this article, says: February 2, 2015 at 6...

  • AC/DC

    Re: $FGEN Have we discussed Fibrogen here before? If yes then please point me to the comment(s). I couldn't find it in ...

  • Avatar

    Since this article was about GILD and there was mention of Simtuzumab, I'm going to take this chance and ask a few quest...

  • DrKSSMDPhD

    Since the time of last year's column on $AKBA, it has overcome the main objection, which was that then it was too expens...

  • DrKSSMDPhD

    Thanks Om. Good to know. FibroGen, which recently went public and has a competing agent, was up 20-odd percent today. I ...

  • Avatar

    From RBC this Am. No position just sharing. Eyedoc just heard on Squawk that sanofi was looking at Petmed takeover. I b...

  • DrKSSMDPhD

    JP...thanks. So obviously a volcano is going to pop here. Probably +phase 2 data for their HIF drug. I may have to get i...

  • Avatar

    After reading Dr KSS's comments on Fibrogen ($FGEN) in the article that he references above, I'm seriously thinking abou...

  • DrKSSMDPhD

    Hi: ironically, just a little while ago, I was speaking with someone who tells me that FibroGen has just been socked wit...

  • DrKSSMDPhD

    Thanks Vivian. I have a healthy respect for the company and will be watching/following. If phase 2 succeeds and they iss...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info